SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-16-010465
Filing Date
2016-01-29
Accepted
2016-01-29 15:23:47
Documents
4
Period of Report
2016-01-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k012916_immucellcorp.htm 8-K 40300
2 UNDERWRITING AGREEMENT BETWEEN THE COMPANY AND CRAIG-HALLUM CAPITAL GROUP LLC, D f8k012916ex1i_immucell.htm EX-1.1 183441
3 OPINION OF PIERCE ATWOOD LLP f8k012916ex5i_immucell.htm EX-5.1 7419
4 PRESS RELEASE OF IMMUCELL CORPORATION, DATED JANUARY 29, 2016 f8k012916ex99i_immucell.htm EX-99.1 14045
  Complete submission text file 0001213900-16-010465.txt   246336
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 161373060
SIC: 2835 In Vitro & In Vivo Diagnostic Substances